Thursday, September 6th, 2018

Are “Point of Care” drug test devices/kits results reliable?


If you choose a high quality device/kit such as the ITS range of point of care drug testing solutions, and you follow the instructions for use – then yes. Point of Care drug testing must be carried out correctly to maintain cost/time efficiency and to ensure accurate results. Our helpful short videos demonstrate the process from start to finish. This is a fairly straightforward process and there are only a few stages that can affect the quality of results. A “positive” screen test result (either via a laboratory or a “Point of Care” drug test device/kit) does not always mean that a person took illegal/legal/prescription drugs and a negative test does not always mean that a person did not take illegal/legal/prescription drugs; there are several factors that influence the reliability of the test results. There is a possibility that other substances and/or factors may interfere with the test and cause incorrect test results.


Recent Posts

185 drivers failed roadside drug tests

185 drivers failed roadside drug tests

Police Scotland say 185 drivers failed roadside drug tests during their festive campaign. For the 1st time officers were able to test for drugs at the roadside. Drug tests for cannabis & cocaine resulted in 185 positive results from 480 drivers stopped. Almost 600 motorists breathalysed between 1 Dec-2 Jan were under the influence of drink/drugs. A total of 8687 drivers were stopped over the period, with 580 of those detected for drink/drug offences. 29 drivers were caught the morning after they had been drinking.

Alcohol Awareness Week

Alcohol Awareness Week

Charity Alcohol Change UK have announced Alcohol Awareness Week (AAW) 2019 will take place from 11-17 November. Are you / your workplace doing anything to support and promote Alcohol Awareness Week?

New controls over prescription drugs Pregabalin and Gabapentin following rising fatalities

New controls over prescription drugs Pregabalin and Gabapentin following rising fatalities

Pregabalin and Gabapentin to be controlled as class C drugs from April 2019 Prescription drugs pregabalin and gabapentin are to be reclassified as class C controlled substances from April 2019, the government announced on 15 October 2018. The move comes after experts highlighted rising numbers of fatalities linked to the drugs. The change means it will be illegal to possess pregabalin and gabapentin without a prescription and it will be illegal to supply or sell them to others.